Author Correction: Daratumumab plus bortezomib, lenalidomide and dexamethasone for transplant-ineligible or transplant-deferred newly diagnosed multiple myeloma: the randomized phase 3 CEPHEUS trial.

• Tác giả: Tahamtan Ahmadi, Nizar J Bahlis, Supratik Basu, Meral Beksac, Marc Braunstein, Jodi Carey, Robin Carson, Katherine Chastain, Yael C Cohen, Thierry Facon, Sebastian Grosicki, Cyrille Hulin, Vania Hungria, Maria Krevvata, Wojciech Legiec, Weiping Liu, Lorena Lopez-Masi, Angelo Maiolino, Josep M Martí, Morio Matsumoto, Aurore Perrot, Ludek Pour, Melissa Rowe, Kenshi Suzuki, Hiroyuki Takamatsu, Mehmet Turgut, Saad Z Usmani, Christopher P Venner, Jessica Vermeulen, Jianping Wang, Sonja Zweegman
• Ngôn ngữ: eng
• Thông tin xuất bản: United States : Nature medicine , 2025
• Bộ sưu tập: NCBI
• ID: 55933